✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
One of these is theendothelin receptor antagonist bosentan.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Acute respiratory distress syndrome is characterized by dyspnea at presentation, tachypnea on physicalexamination, findings of bilateral infiltration in chest radiography, refractory hypoxia, and high mortality.Although the main treatment approach is to address the underlying disease, there are also pharmacologicaland nonpharmacological options for supportive treatment.
📊
Key Findings & Data:There is currently no pharmacological agent withproven efficacy in this syndrome, and many drugs are being studied for this purpose.
💡
Conclusion & Impact:One of these is theendothelin receptor antagonist bosentan.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Acute respiratory distress syndrome is characterized by dyspnea at presentation, tachypnea on physicalexamination, findings of bilateral infiltration in chest radiography, refractory hypoxia, and high mortality.Although the main treatment approach is to address the underlying disease, there are also pharmacologicaland nonpharmacological options for supportive treatment. There is currently no pharmacological agent withproven efficacy in this syndrome, and many drugs are being studied for this purpose. One of these is theendothelin receptor antagonist bosentan.
🔖
Cite This Article
KARAMAN, A. (2022). What Else Can We Use in The Discrimination of Activated MS Plaques in Addition to Diffusion MRI?. Eurasian Journal of Medicine, Cilt: 52 - Sayı: 1, 98–99. https://ajindex.com/articles/508878